Follow
Kas Steuten
Kas Steuten
Verified email at lic.leidenuniv.nl
Title
Cited by
Cited by
Year
Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19
K Steuten, H Kim, JC Widen, BM Babin, O Onguka, S Lovell, O Bolgi, ...
ACS infectious diseases 7 (6), 1457-1468, 2021
832021
Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents
IM Hagemans, PJ Wierstra, K Steuten, JDM Molkenboer-Kuenen, ...
Journal of nanobiotechnology 20 (1), 1-15, 2022
82022
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
MJ Van Elsas, JMS Van der Schoot, A Bartels, K Steuten, D Van Dalen, ...
International journal of molecular sciences 23 (15), 8707, 2022
42022
Site-specific chemo-enzymatic modification of antibodies to target the immune system
IM Hagemans
[Sl]:[Sn], 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–4